Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Divalproex Sodium 125 MG Delayed Release Oral Capsule [Depakote]

Known as: Depakote Sprinkle 125 MG Delayed Release Oral Capsule, Depakote 125 MG Delayed Release Oral Sprinkle Capsule, DIVALPROEX SODIUM 125 mg ORAL CAPSULE [Depakote] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The importance of a prolonged observation period following asymptomatic enteric-coated valproic acid acute overdose, because of… Expand
Review
2010
Review
2010
Sir, In 2005–2007 we surveyed mental health services in Lebanon [1]. At the time, we found a paucity of community-based mental… Expand
2008
2008
  • 2008
  • Corpus ID: 16302945
Depakote Sprinkle Capsules (divalproex sodium) Initial U.S Approval: 1989 WARNING: LIFE THREATENING ADVERSE REACTIONS See full… Expand
  • table 1
  • table 2
  • figure 2
  • table 4
2005
2005
Introduction: Hemoperfusion, with or without hemodialysis, has been used to treat patients suffering from severe valproic acid… Expand
1995
1995
&Low-dose valproate semisodium [divalproex sodium, Depakote®; Abbott] may be effective in stabilising symptoms in patients with… Expand
1990
1990
To determine the absorption characteristics of a new dosage form of divalproex sodium consisting of coated particles in a pull… Expand